Alignment Healthcare (NASDAQ:ALHC) President Sells $626,100.00 in Stock

Key Points

• President Dawn Christine Maroney sold 30,000 shares on April 15 at an average price of $20.87 for a total of $626,100 under a pre-arranged Rule 10b5-1 plan, reducing her stake by 2.83% to 1,028,813 shares.
• Shares traded down about 1.7% to $20.92 the same day; the company recently topped EPS estimates (‑$0.05 vs. ‑$0.15) with revenue up 44.4% year-over-year, and the Street consensus target is $24.75 (market cap ~$4.27B).
• Institutional ownership is high (86.19%), with large firms like T. Rowe Price and Invesco materially increasing their positions in the fourth quarter.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 30,000 shares of the company's stock in a transaction on Wednesday, April 15th. The stock was sold at an average price of $20.87, for a total value of $626,100.00. Following the completion of the sale, the president owned 1,028,813 shares of the company's stock, valued at $21,471,327.31. This represents a 2.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Dawn Christine Maroney also recently made the following trade(s):

• On Wednesday, March 18th, Dawn Christine Maroney sold 36,749 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.84, for a total value of $655,602.16.
• On Monday, March 16th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.48, for a total value of $524,400.00.
• On Thursday, March 12th, Dawn Christine Maroney sold 29,113 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.45, for a total value of $508,021.85.
• On Tuesday, February 17th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.63, for a total value of $618,900.00.
• On Thursday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $22.48, for a total transaction of $674,400.00.

Alignment Healthcare Stock Down 1.7%

Shares of ALHC traded down $0.36 during mid-day trading on Wednesday, hitting $20.92. 1,370,751 shares of the company traded hands, compared to its average volume of 3,456,949. Alignment Healthcare, Inc. has a 1-year low of $11.63 and a 1-year high of $23.87. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.80. The company has a market capitalization of $4.27 billion, a PE ratio of -2,089.91, a price-to-earnings-growth ratio of 3.11 and a beta of 1.20. The business has a 50 day moving average of $19.22 and a 200 day moving average of $19.11.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) EPS for the quarter, topping analysts' consensus estimates of ($0.15) by $0.10. The company had revenue of $1.01 billion during the quarter, compared to analysts' expectations of $1 billion. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.The firm's revenue was up 44.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.16) EPS. Equities research analysts anticipate that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Analyst Upgrades and Downgrades

ALHC has been the topic of several recent research reports. Weiss Ratings restated a "sell (d-)" rating on shares of Alignment Healthcare in a report on Wednesday, January 21st. KeyCorp reiterated an "overweight" rating and issued a $28.00 price objective on shares of Alignment Healthcare in a report on Thursday, January 22nd. Wall Street Zen cut Alignment Healthcare from a "buy" rating to a "hold" rating in a report on Saturday, March 7th. Robert W. Baird set a $28.00 price objective on Alignment Healthcare in a report on Friday, January 30th. Finally, TD Cowen upped their price objective on Alignment Healthcare from $18.50 to $25.00 and gave the company a "buy" rating in a report on Friday, January 16th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Alignment Healthcare presently has an average rating of "Moderate Buy" and a consensus target price of $24.75.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in ALHC. T. Rowe Price Investment Management Inc. increased its position in shares of Alignment Healthcare by 0.6% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 12,643,784 shares of the company's stock worth $249,715,000 after purchasing an additional 79,268 shares during the last quarter. Invesco Ltd. boosted its holdings in Alignment Healthcare by 38.9% during the fourth quarter. Invesco Ltd. now owns 6,202,592 shares of the company's stock worth $122,501,000 after buying an additional 1,735,962 shares in the last quarter. Mercer Global Advisors Inc. ADV boosted its holdings in Alignment Healthcare by 6.9% during the fourth quarter. Mercer Global Advisors Inc. ADV now owns 15,452 shares of the company's stock worth $305,000 after buying an additional 996 shares in the last quarter. Mackenzie Financial Corp boosted its holdings in Alignment Healthcare by 25.6% during the fourth quarter. Mackenzie Financial Corp now owns 46,917 shares of the company's stock worth $901,000 after buying an additional 9,552 shares in the last quarter. Finally, nVerses Capital LLC bought a new stake in Alignment Healthcare during the fourth quarter worth approximately $396,000. 86.19% of the stock is owned by hedge funds and other institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc NASDAQ: ALHC is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.